To further reveal the mechanisms underlying the helper functions of NK cells in CD8+ T cell‐dependent anti‐PD‐L1 immunotherapy, we set out to determine tumor growth after anti‐PD‐L1 immunotherapy in mice with NK cell‐specific deletion of Prf1, Ifng, Tbx21, or Eomes. The gene discussed is IFNG; the disease is neoplasm.